National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 4) (No. PB 58 of 2013)

Link to law: https://www.comlaw.gov.au/Details/F2013L01585

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now
 
PB 58 of 2013
 
National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 4)
National Health Act 1953
I, GREG O’TOOLE, Assistant Secretary (Acting), Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the
Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated                   14        August 2013
 
 
 
 
 
 
 
 
 
GREG O’TOOLE
 
Assistant Secretary (Acting)
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health and Ageing
 
 
 
Part 1         Preliminary
1              Name of Determination
         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 4).
         (2)   This Determination may also be cited as PB 58 of 2013.
2              Commencement
                This Determination commences on 1 September 2013.
3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1             Amendments
 
(Section 3)
 
[1]     Schedule 1, after item dealing with Tadalafil
 
Insert
 
Tafluprost